CLIA Announces New 2024 Updates
Changes to CLIA requirements for Analytical Quality may affect your proficiency testing and quality control programs. Effective July 11, 2024, these r…
Read More Our line of MDx-Chex® molecular diagnostic controls provides an all-in-one solution for verifying the performance of the BIOFIRE® BCID2 and VERIGENE® BC-GP and BC-GN sepsis tests. Comprehensive and easy-to-use, MDx-Chex controls evaluate the entire assay process, from cell lysis, DNA extraction and purification to nucleic acid detection and analysis.
ESCMID 2024 Presentation:
Evaluate the entire analytical process of the BIOFIRE® Blood Culture Identification 2 (BCID2) Panel for sepsis…
Evaluate the entire analytical process of the Luminex VERIGENE® BC-GP and BC-GN…